Evidence map›Paper›PMID 38829050›Full record

ArticleAntimicrobial agents and chemotherapy2024

High variance in quantification of

Kathleen F Walsh, Myung Hee Lee, Kayvan Zainabadi, Stalz Charles Vilbrun, Marc Antoine Jean Juste, Yvetot Joseph, Gertrude Royal, Kohta Saito, Kathrine McAulay, Jean W Pape and 1 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kathleen F WalshCenter for Global Health, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0002-9001-3918
Myung Hee LeeCenter for Global Health, Weill Cornell Medicine, New York, New York, USA.
Kayvan ZainabadiCenter for Global Health, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0003-3134-1783
Stalz Charles VilbrunDepartment of Medicine, Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infectieuses Opportunistes (GHESKIO), Port-au-Prince, Haiti.
Marc Antoine Jean JusteDepartment of Medicine, Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infectieuses Opportunistes (GHESKIO), Port-au-Prince, Haiti.
Yvetot JosephDepartment of Medicine, Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infectieuses Opportunistes (GHESKIO), Port-au-Prince, Haiti.
Gertrude RoyalDepartment of Medicine, Groupe Haïtien d'Étude du Sarcome de Kaposi et des Infectieuses Opportunistes (GHESKIO), Port-au-Prince, Haiti.
Kohta SaitoDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Kathrine McAulayCenter for Global Health, Weill Cornell Medicine, New York, New York, USA.
Jean W PapeCenter for Global Health, Weill Cornell Medicine, New York, New York, USA.
Daniel FitzgeraldCenter for Global Health, Weill Cornell Medicine, New York, New York, USA.

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Viable but Nonculturable MtbU19AI111143 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GLICKMAN, MICHAEL HAGGAI, GLICKMAN, MICHAEL S · 2014 to 2020
$48.6M
Pharmacology & ImmunoPathology (PIP) CoreU19AI162568 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI EHRT, SABINE · 2021 to 2025
$13.0M
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating StatesK08AI139360 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAITO, KOHTA · 2019 to 2023
$860k
Sentinel populations and transmission hotspots of isoniazid-resistant tuberculosisK23AI175686 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Kathleen F Walsh · 2023 to 2026
$782k
NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002384NIAID NIH HHS K08 AI139360NIAID NIH HHS K23 AI175686NIAID NIH HHS U19 AI111143NIAID NIH HHS U19 AI162568
6 · The paper itself

Abstract

We examined the correlation between three different methods of

Indexed as

Bacterial LoadMycobacterium tuberculosisAdultFemaleHumansMaleProspective Studiesdifferentially detectableearly bactericidalMycobacterium tuberculosisquantification

Identifiers

PMID38829050
PMCPMC11232379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.